Loss of HIF-1α accelerates murine FLT-3ITD-induced myeloproliferative neoplasia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Leukemia

• Publication date

  2015-06-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2015.156PMID 26104662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolic requirements for the maintenance of self-renewing stem cells

  2014cited by this paper
• HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia.

  2014cited by this paper
• Hif-2α is not essential for cell-autonomous hematopoietic stem cell maintenance.

  2013cited by this paper
• Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells.

  2013cited by this paper
• Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation.

  2013cited by this paper
• A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice

  2013cited by this paper
• FLT3-ITDs Instruct a Myeloid Differentiation and Transformation Bias in Lymphomyeloid Multipotent Progenitors

  2013cited by this paper
• HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.

  2013cited by this paper
• Hypoxia-inducible factors in physiology and medicine.

  2012cited by this paper
• FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm.

  2012cited by this paper
• Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

  2011cited by this paper
• Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche.

  2011cited by this paper
• HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells.

  2011cited by this paper
• Regulation of the HIF-1alpha level is essential for hematopoietic stem cells.

  2010cited by this paper
• The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche.

  2010cited by this paper
• Hypoxia, HIF1 and glucose metabolism in the solid tumour

  2008cited by this paper
• Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells.

  2008cited by this paper
• FoxO transcription factors and stem cell homeostasis: insights from the hematopoietic system.

  2007cited by this paper
• FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia.

  2007cited by this paper
• Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.

  2006cited by this paper
• Hematopoietic, angiogenic and eye defects in Meis1 mutant animals

  2004cited by this paper
• Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha.

  2004cited by this paper
• BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin.

  2002cited by this paper
• Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches.

  2001cited by this paper
• Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

  2000cited by this paper
• Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth

  2000cited by this paper
• Inducible gene targeting in mice

  1995cited by this paper

• Roxadustat induces erythroid differentiation of erythroleukemia cells through the hypoxia inducible factor-α / GATA binding protein 1 axis.

  2025cites this paper
• Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells

  2024cites this paper
• Therapeutic Targeting of the Leukaemia Microenvironment

  2021cites this paper
• Bone marrow niche dysregulation in myeloproliferative neoplasms

  2020cites this paper
• HIF1/2-exerted control over glycolytic gene expression is not functionally relevant for glycolysis in human leukemic stem/progenitor cells

  2019cites this paper
• Hypoxia Pathway Proteins in Normal and Malignant Hematopoiesis

  2019cites this paper
• Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38- cells through iron chelation, induction of ROS, and inhibition of HIF1α expression.

  2019cites this paper
• HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia

  2018cites this paper
• Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia

  2018cites this paper
• The Biology of Hematopoietic Stem Cells: transgenic approaches to Dissect Native and Perturbed Hematopoiesis

  2017cites this paper
• The hypoxia signalling pathway in haematological malignancies

  2017cites this paper
• Leukemia Stem Cells Microenvironment.

  2017cites this paper
• Myeloid malignancies and the microenvironment.

  2017cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Leukemias

  2016cites this paper
• Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact

  2016cites this paper
• Potential Pitfalls of the Mx1-Cre System: Implications for Experimental Modeling of Normal and Malignant Hematopoiesis

  2016cites this paper
• Oxidative stress and hypoxia in normal and leukemic stem cells.

  2016cites this paper